Childhood vesiculobulous disorder (toxic epidermal necrolysis) in a resource constrained setting
Keywords:
vesiculobulous disorder, child, toxic epidermal necrolysis, resource constraintAbstract
We report a case of childhood vesiculobulous disorder of the severity of Toxic Epidermal Necrolysis(TEN) in a 4 year ten month old female child resulting from caregiver prescribed medication. She is one of 4 children of a non consanguineous marriage with no family history of similar adverse drug reactions. She was initially managed in a private hospital before referral to our centre where we observed constraints of funds and crisis of confidence on the part of the parents. The need for enlightenment and counseling of care givers on cause of illness and advocacy for special funds for adverse drug events especially for indigent patients is hereby highlighted. Also the importance of optimization of available health care resources even in the midst of poor circumstances is emphasized.
References
Stevens A.M, Johnson FC; a new eruptive fever associated with stomatitis and ophthalmia; report of two cases in children. American journal of diseases in children. 1922, 24:526-533
Lyell A: Toxic epidermal necrolysis: an eruption resembling scalding of the skin Br J Dermatol. 1956, 68:355-361.
Joseph G. Morelli, vesiculobullous disorders:Nelson textbook of pediatrics, 18th ed. Elsevier science USA, 2007
Thomas Harr and E French. Toxic epidermal necrolysis and Stevens-Johnson syndrome. Orphanet Journal of rare diseases 2010 Doi: 10-1186/1750-1172-5-39
Pierre Dominique, Ghislain M.D, Jean-Clarke, Rougeau, M.D. Treatment of severe drug reactions: Stevens-Johnson syndrome, Toxic epidermal necrolysis and Hypersensitivity syndrome
Dermatology online journal 8(1); 5
Chung WH, Hung S.I, Hong HS, HS sh ms, Yang l.C, HO HC, Wu JY, Chen YT: medical genetics: a marker for Stevens-Johnson syndrome. Nature. 2004, 428:486-10. 1038/428486a
Hung SI, ChungWh, Liou LB, Chu CL, Liu M, Yang LC, Hong HS: HLAB*5801 allele as a genetic marker for severe cutaneous adverse reaction caused by allopurinol. PWC NGH Acad Sh USA. 2005, 102:4134-4139 10.1073/pnas. 0409500102
Kazeem G.R. Cox J. Aponte, et al. High-resolution HLA genotyping and severe reactions in lamotrigine-treated patients. Pharmacogenet Genomics, 19 (2009), pp661-665
Descamps V, bouscarat F, Laglenne S et al. Human Herpes 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome Br J. dermetol. 1997; 137:605-8
Suzuki Y, Inagi R, Aono T, Yamanishi K, Shiohara T. Human Herpes virus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome.
Arch Dermatol. 1998; 134:1108-12
Descamps V, Valance A, Edlinger C et al. Association of human herpes virus 6 infections with drug reaction with eosinophilia and systemic symptoms. Arch Dermatol. 2001; 137:301-4
epidermal necrolysis and Stevens- Johnson syndrome does early withdrawal of causative drugs decrease the risk of death? Arch Dermatol 2000; 136:323-327
Kardan SH, Jonkman MF, Dexamethasone pulse therapy for Stevens- Johnson syndrome/ toxic epidermal necrolysis. Acta Derm Venerol. 2007, 87:144-148.10.2340100015555-0214
Funbacke A, Berlin G, Anderson C, Sjoberg F: lack of significant treatment effect of plasma exchange in the treatment of drug- induced toxic epidermal necrolysis? Intensive care med. 1991, 25:1307-1310.
Bastuji-Garin S, Fouchard N, Bertocchi M, et al. (2000). "SCORTEN: a severity-of-illness scores for toxic epidermal necrolysis". 115 (2). J Invest Dermatol: 149–53.
Endorf F.W, Cancio L.C, Gibran N.S. Toxic epidermal necrolysis clinical guidelines. J Burn care Res. 2008; 29:706-712
Clayton N.A, Kennedy P.J. Management of dysphasia in the toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS). Dysphasia 2007; 22:18
Downloads
Published
Issue
Section
License
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
How to Cite
